Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach
Richard F Pollock,1 Barrie Chubb,2 William J Valentine,1 Simon Heller3 1Health Economics and Outcomes Research, Ossian Health Economics and Communications GmbH, Basel, Switzerland; 2EU-HEOR, Novo Nordisk Limited, Gatwick, UK; 3Department of Oncology & Metabolism, The University of Sheffield,...
Saved in:
Main Authors: | Pollock RF, Chubb B, Valentine WJ, Heller S |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/79f0012d1c114bc8958c83db718ff9d6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypoglycemia in type 2 diabetes patients treated with insulin: the advantages of continuous glucose monitoring
by: Vadim Valer'evich Klimontov, et al.
Published: (2014) -
The value of patient-reported outcomes in patients with type 2 diabetes mellitus receiving insulin therapy: assessment of quality of life and hypoglycemia problems
by: Tat'yana Ivanovna Ionova, et al.
Published: (2015) -
Comparative efficacy assessment for various insulin regimens in patients with type 2 diabetes mellitus, ischaemic heart disease and frequent hypoglycemic events
by: Vladimir Ivanovich Kudinov, et al.
Published: (2012) -
Insulin pump therapy in children with diabetes mellitus: practice of Krasnoyarsk Krai
by: Tatiana Evgen'evna Taranushenko, et al.
Published: (2012) -
Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics
by: Le Floch J
Published: (2010)